Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04458571 · ClinicalTrials.gov registry record

Effect of CRRT Duration on Solute Removal

A clinical trial, sponsored by University of Colorado, Denver.

Completed
Registry status
112
Enrollment target

NCT04458571: Completed study, sponsored by University of Colorado, Denver.

NCT04458571 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04458571 has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
112 participants
Enrollment target

Study Summary

The only FDA approved treatment for acute kidney injury(AKI) for patients is Dialysis-also known as renal replacement therapy(RRT). Continuous RRT(CRRT) is the preferred method in the ICU. Patients receiving CRRT with AKI will be recruited to the study where blood and effluent will be collect prior to CRRT initiation and Day 1,2,and 3 following. Metabolites will be assessed to determine solute removal, and also to identify the time at which solute removal has reached steady state. This will help determine the best duration of CRRT.

Primary Outcome

The primary outcome of interest is the binary identification of steady state for each metabolite. Approximately 100 metabolites will be measured including amino acids, phosphorus, creatinine, and BUN

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2020-10-01
Est. Completion 2022-12-21
University of Colorado, Denver

1,283 total trials

What the finished NCT04458571 record still lists

NCT04458571 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT04458571 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04458571 about?

NCT04458571 is a clinical study titled "Effect of CRRT Duration on Solute Removal". The only FDA approved treatment for acute kidney injury(AKI) for patients is Dialysis-also known as renal replacement therapy(RRT). Continuous RRT(CRRT) is the preferred method in the ICU. Patients receiving CRRT with AKI will be recruited to the study where blood and effluent will be collect prior ...

What is the current status of trial NCT04458571?

This trial is currently completed. The enrollment target is 112 participants. The study started on 2020-10-01. Estimated completion is 2022-12-21.

Who is sponsoring clinical trial NCT04458571?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04458571, the US trial registry maintained by the National Library of Medicine. NCT04458571 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.